Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Pharmacology|September 13, 2019
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective studyNaoto Okada, Masayuki Chuma, Momoyo Azuma, et al.
Biological & Pharmaceutical Bulletin|January 12, 2026
Exploratory Analysis for Development Predictive Models of Immune Checkpoint Inhibitor-Induced Myocarditis Using a Nationwide Claims DatabaseReina Yamamoto, Hirofumi Hamano, Koki Nakagomi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 3, 2015
Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathwayYasumasa Ikeda, Hirofumi Hamano, Akiho Satoh, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combinationTakahiro Niimura, Mitsuhiro Goda, Koji Miyata, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2025
Unravelling the cardioprotective effects of calcitriol in Sunitinib-induced toxicity: A comprehensive in silico and in vitro studyYoshika Sakamoto, Takahiro Niimura, Mitsuhiro Goda, et al.
Leukemia Research|April 19, 2026
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBaseJun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, et al.
Cardio-Oncology (London, England)|March 5, 2025
Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapyAya F Ozaki, Michael Sayer, Hirofumi Hamano, et al.
Biological & Pharmaceutical Bulletin|September 29, 2024
Letermovir at a Prophylactic Dose for Cytomegalovirus Infection in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study in JapanYasuhisa Tatebe, Yohei Manabe, Yuta Tanaka, et al.
European Urology Focus|August 1, 2022
Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting SystemJun Matsumoto, Naohiro Iwata, Shogo Watari, et al.
Toxicology and Applied Pharmacology|July 23, 2023
Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databasesMami Neishi, Hirofumi Hamano, Takahiro Niimura, et al.
Pageof 9